27 February 2019 | News
Singapore Cancer Society and National Cancer Centre Ink Partnership to Provide Holistic and Seamless Cancer Support to More Singaporeans & Intensify Upstream Prevention Methods to Reduce Cancer Incidence
Singapore Cancer Society (SCS) and the National Cancer Centre Singapore (NCCS) have inked a partnership that will provide Singaporeans greater access to integrated cancer care.
Signed by Mr Albert Ching, CEO of SCS and Professor William Hwang, Medical Director of NCCS, the partnership will see more Singaporeans benefit from a seamless experience when managing their cancer and hopefully reduce cancer incidence through an enhanced genetics screening programme championed by both parties.
Currently, the Cancer Genetics Service (CGS) at NCCS provides cancer risk assessment services to people with family histories of cancer. The services, provided by clinicians with expertise in both genetics and oncology, involve cancer risk assessments, pre and post-test genetic counselling, facilitation of genetic testing and subsequent cancer risk management plans tailored to the individual and their relatives. The CGS team is also actively involved in translational and clinical human genomics and health services research.
This will be the first time a government healthcare institution and voluntary welfare organisation are coming together to collaborate on upstream prevention efforts in addition to their current activities. A key advancement in upstream prevention measures is the adoption of genetics screening to identify potential cancer genes in a strategic bid to reduce cancer incidence.